Fedratinib
Fedratinib Brand Name– INREBIC What is Fedratinib Fedratinib is a Janus associated kinase-2 (JAK2) and FMS-like tyrosine kinase-3 (FLT3) inhibitor approved for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. Fedratinib labeling has a boxed warning for encephalopathy, including Wernicke encephalopathy; thiamine deficiency should be …
